Enthorin Therapeutics, LLC, a biotechnology company focused on circuit-modulating treatments for neurological and neurodevelopmental disorders, announced that its licensing partner for MRM-3379 ...

Mutations in FMR1, the gene encoding fragile X messenger ribonucleoprotein 1 (FMRP), located at Xq27.3 and discovered in 1991, are the leading single-gene causes of autism and intellectual disability.

March 16, 2010 (Updated March 18, 2010) — Chromosomal microarray analysis (CMA) is at least 3 times more effective at identifying genetic abnormalities in autism spectrum disorder (ASD) than other ...

The nation’s pediatricians are getting new guidelines for how to go about evaluating children who present with global developmental delay or intellectual disability. Doctors should use genetic testing ...